EUVIMEDOntdek EUVIMED
Übersichtsarbeit

Maturing differentiated human pluripotent stem cells in vitro : methods and challenges

Daniele Ottaviani iD, Menno Ter Huurne, David A Elliott iD, Milena Bellin iD, Christine L Mummery iD

Development · 2023-06-01 · 150 (11)

DOI: 10.1242/dev.201103 ↗

At a glance

Übersichtsarbeit in Development, published online on 2023-06-01. Written by Daniele Ottaviani and 4 co-authors. Institution: Department of Biology, University of Padova, Padova 35131, Italy. Major MEDLINE topics: Pluripotent Stem Cells, Induced Pluripotent Stem Cells. Cited 36 times so far (Crossref); 100 references. Funded by: European Research Council, Fondazione Umberto Veronesi, Novo Nordisk Fonden.

SamenvattingSubjectsBibliografische gegevensCiteRelated studies

Abstract (original language)

Human pluripotent stem cells (hPSCs), derived from individuals or genetically modified with disease-related mutations and variants, have revolutionised studies of human disease. Researchers are beginning to exploit the extraordinary potential of stem cell technology to screen for new drugs to treat intractable diseases, ideally without side-effects. However, a major problem is that the differentiated cell types on which these models are based are immature; they resemble fetal and not adult cells. Here, we discuss the nature and hurdles of hPSC maturation, using cardiomyocytes as an example. We review methods used to induce cardiomyocyte maturation in culture and consider remaining challenges for their integration into research on human disease and drug development pipelines.

Subjects

MeSH terms (MEDLINE)

Pluripotent Stem CellsInduced Pluripotent Stem CellsHumansMyocytes, CardiacCell Differentiation

Author keywords

Cardiac maturationCardiac microtissuesCardiac organoidsEngineered heart tissuehiPSC-derived cardiomyocytes

Authors and institutions

  • Department of Biology, University of Padova, Padova 35131, Italy.
  • Veneto Institute of Molecular Medicine, Padova 35129, Italy.
  • Murdoch Children's Research Institute, Melbourne 3052, Australia.
  • The Novo Nordisk Foundation Center for Stem Cell Medicine (reNEW), Copenhagen 2200, Denmark.
  • Departmant of Anatomy and Embryology, Leiden University Medical Center, Leiden 2333ZC, The Netherlands.
  • Department of Applied Stem Cell Technologies, University of Twente, Enschede 7522, The Netherlands.

ORCID profiles: Daniele Ottaviani, David A Elliott, Milena Bellin, Christine L Mummery

Funding

  • European Research Council
  • Fondazione Umberto Veronesi
  • Novo Nordisk Fonden

Cite

APA

Ottaviani, D., Ter Huurne, M., Elliott, D. A., Bellin, M., & Mummery, C. L. (2023). Maturing differentiated human pluripotent stem cells in vitro : methods and challenges. Development, 150(11). https://doi.org/10.1242/dev.201103

Vancouver

Ottaviani D, Ter Huurne M, Elliott DA, Bellin M, Mummery CL. Maturing differentiated human pluripotent stem cells in vitro : methods and challenges. Development. 2023;150(11). doi:10.1242/dev.201103

BibTeX
@article{Ottaviani2023,
  author = {Ottaviani, Daniele and Ter Huurne, Menno and Elliott, David A and Bellin, Milena and Mummery, Christine L},
  title = {Maturing differentiated human pluripotent stem cells in vitro : methods and challenges},
  journal = {Development},
  year = {2023},
  volume = {150},
  number = {11},
  doi = {10.1242/dev.201103}
}
Start for free →